This decline in profitability was primarily attributed to a challenging consumer landscape, higher marketing expenditures, and rising labour and freight costs, although these pressures were partly offset by moderating ingredient costs and lower interest expenses.
With H1 performance supporting its unchanged 2026 guidance, the company enters the second half with continued momentum across nutrition, health and beauty markets.
The US baking mix maker is focusing on its main product lines while using licensing deals to expand into new categories and channels.
With improved first-half EBITA and strengthened leadership in the United States and Brazil, the company enters the second half of 2026 focused on operational execution, customer relationships, and continued expansion across specialty chemicals and ingredients markets.
Brenntag attributed the performance to coordinated pricing strategies and effective stocking decisions in North America and Europe, the Middle East and Africa.